Business Context and Reporting Period
Company: Alphatec Holdings, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 8, 2012
Event: Entry into a Material Definitive Agreement (Equity Line of Credit).
Key Financial Metrics
This filing reports on a financing arrangement rather than periodic operating results. Specific revenue, profit, cash flow, or margin data is not provided in this document.
- Facility Size: Up to $25 million in common stock purchases over a 24-month term.
- Commitment Fee: $500,000 paid via issuance of 231,045 shares of common stock.
- Transaction Costs: Company agreed to pay up to $25,000 of the investor's legal fees.
- Share Pricing: 90% of the volume-weighted average price (VWAP) of the company's stock over the 15 trading days prior to the closing date.
Material Changes and Transaction Terms
On May 8, 2012, Alphatec entered into an Investment Agreement with Eclipse Advisors, LLC. Key terms include:
- Structure: The company may issue "put notices" to sell stock in two tranches over a 31-day period. Eclipse is obligated to purchase 50% of the specified dollar amount on day 16 and the remaining 50% on day 31.
- Volume Limits: Sales are capped at the amount requiring stockholder approval under NASDAQ Listing Rule 5635 unless approval is obtained.
- Price Protection: If the stock price falls below a threshold set by the company during a put period, the company may cancel the notice, reducing the obligation to sell to no more than 50% of the original amount.
- Penalties: If the company fails to deliver shares within ten trading days of the settlement date, it must pay liquidated damages in cash or restricted shares at Eclipse's option.
Outlook, Risks, and Contingencies
Management Commentary: The filing establishes a flexible financing mechanism to raise capital over the next two years without immediate dilution beyond the commitment fee shares.
Risks and Contingencies:
- Dilution: Future issuance of shares under the agreement will dilute existing shareholders.
- Market Price Dependency: The actual proceeds and number of shares issued depend on the company's stock price at the time of sale.
- Regulatory Compliance: The transaction is subject to NASDAQ listing rules and securities laws.
- Indemnification: The company has agreed to indemnify Eclipse against certain liabilities related to securities laws and NASDAQ regulations.
Investor Verification Checklist
- Verify the current stock price to assess the potential dilution impact of the $25 million facility.
- Review the full Investment Agreement (Exhibit 10.1) for specific threshold prices and cancellation rights.
- Check subsequent filings to determine if any put notices have been issued and the resulting share count.
- Confirm whether stockholder approval has been sought or obtained for sales exceeding NASDAQ Rule 5635 limits.
- Monitor the company's cash position to understand the urgency of utilizing this credit line.